JOHN FREDERICK BRANDSEMA MD
Prescription History 1275889792
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology in Philadelphia, PA


Quality Rating: 85.48 out of 100 score

NPI Status: Active since August 02, 2012

Contact Information

3401 CIVIC CENTER BLVD
CTRB 10010
PHILADELPHIA, PA
ZIP 19104
Phone: (215) 590-1719
Fax: (215) 590-1771

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOHN FREDERICK BRANDSEMA MD, an active Neurology with Special Qualifications in Child Neurology specialist practicing in Philadelphia, PA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 27 documented patient claims. Among these therapy options, the most frequently utilized medication is Evrysdi, which accounts for 27 claims alone.

Medication Index

No matching medications currently found on file.

Evrysdi

Generic Formulation: RisdiplamSpecialty: Neurology
Provider Metrics Summary
Total Claims 27
30-Day Fills 31.4
Days Supply 912
PA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.6
Peer Average Days Supply729
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $966,297.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$35,788.81

State Avg Cost Per Claim

$27,164.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain muscle disorder (spinal muscular atrophy - SMA).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JOHN FREDERICK BRANDSEMA MD provides transparency into local medical care patterns within Philadelphia, PA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology with Special Qualifications in Child Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.